Mackattack -
even taking out the $4M manufacture cost for material which completes PAB's contribution to the trial it still retains it position at #2 of the six companies on cash to mc ratio. Plus last calendar year inclusive of R&D rebate they only burned $3M. Yes AHZ (which I also hold) is on the path to sustainability but they are also burning far more capital after revenue along the way with $6M burn last calendar year.
amgen looking to expand onyx kyprolis, page-18
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.258M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 24181784 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7489761 | 10 |
View Market Depth
| Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable